Actual management of ductal carcinoma in situ of the breast

Archives of Gynecology and Obstetrics

Volumn 280, Issue 5, 2009, Pages 699-705

  Maass, Nicolai ^a   Alkasi, Özkan ^b   Bauer, Maret ^b   Jonat, Walter ^b   Souchon, R ^c   Meinhold Heerlein, Ivo ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c AKH Hagen ^*  (Germany)

Author keywords

Axillary dissection; Breast conserving therapy; Irradiation; Mastectomy; Resection margins; Sentinel lymph node biopsy; Tamoxifen; Van Nuys prognostic index

Indexed keywords

AROMATASE INHIBITOR; GONADORELIN DERIVATIVE; RALOXIFENE; TAMOXIFEN;

AXILLARY LYMPH NODE; CANCER GRADING; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; INTRADUCTAL CARCINOMA; LYMPH NODE DISSECTION; MAMMOGRAPHY; MASTECTOMY; MENOPAUSAL SYNDROME; PRACTICE GUIDELINE; PROGNOSIS; REVIEW;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT;

EID: 70349482816     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-009-0999-y     Document Type: Review

References (42)

1. GD Leonard SM Swain 2004 Ductal carcinoma in situ, complexities and challenges J Natl Cancer Inst 96 906 920 15199110
2. ER Frykberg KI Bland 1994 Overview of the biology and management of ductal carcinoma in situ of the breast Cancer 74 350 361 8004607 1:STN:280:DyaK2c3ntlWhsw%3D%3D
3. VL Ernster R Ballard-Barbash WE Barlow, et al. 2002 Detection of ductal carcinoma in situ in women undergoing screening mammography J Natl Cancer Inst 94 1546 1554 12381707
4. KC Chan WF Knox G Sinha, et al. 2001 Extent of excision margin width required in breast conserving surgery for ductal carcinoma in situ Cancer 91 9 16 10.1002/1097-0142(20010101)91:1<9::AID-CNCR2>3.0.CO;2-E 11148554 10.1002/1097-0142(20010101)91:1<9::AID-CNCR2>3.0.CO;2-E 1:STN:280:DC%2BD38%2Fgs1SksA%3D%3D (Pubitemid 32052608)
5. VL Ernster J Barclay K Kerlikowske, et al. 2000 Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program Arch Intern Med 160 953 958 10.1001/archinte.160.7.953 10761960 10.1001/archinte.160.7.953 1:STN:280:DC%2BD3c3it1GqtQ%3D%3D
6. LJ Solin J Kurtz A Fourquet, et al. 1996 Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast J Clin Oncol 14 754 763 8622021 1:STN:280:DyaK287os1Wquw%3D%3D (Pubitemid 26085518)
7. B Fisher J Dignam N Wolmark, et al. 1999 Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial Lancet 353 1993 2000 10.1016/S0140-6736(99) 05036-9 10376613 10.1016/S0140-6736(99)05036-9 1:CAS:528:DyaK1MXkt1Cnsrk%3D (Pubitemid 29271743)
8. K Kerlikowske A Molinaro I Cha, et al. 2003 Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy J Natl Cancer Inst 95 1692 1702 14625260
9. HR MacDonald MJ Silverstein H Mabry, et al. 2005 Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins Am J Surg 190 521 525 10.1016/j.amjsurg.2005.06.005 16164913 10.1016/j.amjsurg.2005.06.005 (Pubitemid 41306068)
10. MJ Silverstein DN Poller JR Waisman, et al. 1995 Prognostic classification of breast ductal carcinoma-in-situ Lancet 345 1154 1157 7723550 10.1016/S0140-6736(95)90982-6 1:STN:280:DyaK2M3ktVejsQ%3D%3D
11. MD Lagios MJ Silverstein 1997 Ductal carcinoma in situ The success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies. Surg Oncol Clin N Am 6 385 392 1:STN:280:DyaK2s3otFylsg%3D%3D
12. N Bijker P Meijnen JL Peterse, et al. 2006 Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853-a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group J Clin Oncol 24 3381 3387 10.1200/JCO.2006.06.1366 16801628 10.1200/JCO.2006.06.1366 (Pubitemid 46638893)
13. AC Neuschatz T DiPetrillo H Safaii, et al. 2001 Margin width as a determinant of local control with and without radiation therapy for ductal carcinoma in situ (DCIS) of the breast Int J Cancer 96 Suppl 97 104 10.1002/ijc.10357 11992392 10.1002/ijc.10357 1:CAS:528:DC%2BD38XjvV2gt78%3D (Pubitemid 34475664)
14. N Patani B Cutuli K Mokbel 2008 Current management of DCIS: a review Breast Cancer Res Treat 111 1 10 10.1007/s10549-007-9760-z 17902049 10.1007/s10549-007-9760-z (Pubitemid 352009229)
15. DL Page WD Dupont LW Rogers, et al. 1995 Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy Cancer 76 1197 1200 10.1002/1097- 0142(19951001)76:7<1197::AID-CNCR2820760715>3.0.CO;2-0 8630897 10.1002/1097-0142(19951001)76:7<1197::AID-CNCR2820760715>3.0.CO;2-0 1:STN:280:DyaK283itlWlsQ%3D%3D
16. MJ Silverstein MD Lagios PH Craig, et al. 1996 A prognostic index for ductal carcinoma in situ of the breast Cancer 77 2267 2274 10.1002/(SICI)1097- 0142(19960601)77:11<2267::AID-CNCR13>3.0.CO;2-V 8635094 10.1002/(SICI)1097-0142(19960601)77:11<2267::AID-CNCR13>3.0.CO;2-V 1:STN:280:DyaK283isVyqsA%3D%3D (Pubitemid 26162419)
17. S Di Saverio F Catena D Santini, et al. 2008 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up Breast Cancer Res Treat 109 405 416 10.1007/s10549-007-9668- 7 17687650 10.1007/s10549-007-9668-7 (Pubitemid 351692055)
18. MJ Silverstein MD Lagios S Groshen, et al. 1999 The influence of margin width on local control of ductal carcinoma in situ of the breast N Engl J Med 340 1455 1461 10.1056/NEJM199905133401902 10320383 10.1056/NEJM199905133401902 1:STN:280:DyaK1M3ktVShtw%3D%3D (Pubitemid 29220544)
19. JS Wong CM Kaelin SL Troyan, et al. 2006 Prospective study of wide excision alone for ductal carcinoma in situ of the breast J Clin Oncol 24 1031 1036 10.1200/JCO.2005.02.9975 16461781 10.1200/JCO.2005.02.9975 (Pubitemid 46638798)
20. I de Mascarel F Bonichon G MacGrogan, et al. 2000 Application of the Van Nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examined by serial macroscopic sectioning: practical considerations Breast Cancer Res Treat 61 151 159 10.1023/A:1006437902770 10942101 10.1023/A:1006437902770 (Pubitemid 30456235)
21. GP Boland KC Chan WF Knox, et al. 2003 Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery Br J Surg 90 426 432 10.1002/bjs.4051 12673743 10.1002/bjs.4051 1:STN:280:DC%2BD3s7ls1yitw%3D%3D (Pubitemid 36458104)
22. SG MacAusland JT Hepel FK Chong, et al. 2007 An attempt to independently verify the utility of the Van Nuys prognostic index for ductal carcinoma in situ Cancer 110 2648 2653 10.1002/cncr.23089 17960606 10.1002/cncr.23089 (Pubitemid 350250333)
23. O Gilleard A Goodman M Cooper, et al. 2008 The significance of the Van Nuys prognostic index in the management of ductal carcinoma in situ World J Surg Oncol 6 61 10.1186/1477-7819-6-61 18564426 10.1186/1477-7819-6-61 (Pubitemid 352025069)
24. B Fisher J Dignam N Wolmark, et al. 1998 Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17 J Clin Oncol 16 441 452 9469327 1:STN:280:DyaK1c7ivFahuw%3D%3D
25. B Fisher S Land E Mamounas, et al. 2001 Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the national surgical adjuvant breast and bowel project experience Semin Oncol 28 400 418 10.1016/S0093-7754(01)90133-2 11498833 10.1016/S0093-7754(01)90133-2 1:STN:280:DC%2BD3Mvlt1yjtQ%3D%3D (Pubitemid 32762083)
26. J Houghton WD George J Cuzick, et al. 2003 Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial Lancet 362 95 102 10.1016/S0140-6736(03)13859-7 12867108 10.1016/S0140-6736(03)13859-7 (Pubitemid 36831018)
27. JP Julien N Bijker IS Fentiman, et al. 2000 Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group EORTC Radiotherapy Group Lancet 355 528 533 10683002 10.1016/S0140-6736(99) 06341-2 1:STN:280:DC%2BD3c7ksFajtQ%3D%3D
28. N Bijker JL Peterse L Duchateau, et al. 2001 Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853 J Clin Oncol 19 2263 2271 11304780 1:STN:280:DC%2BD3M3mtFOhtQ%3D%3D
29. MB Daly 2006 Tamoxifen in ductal carcinoma in situ Semin Oncol 33 647 649 10.1053/j.seminoncol.2006.08.019 17145343 10.1053/j.seminoncol.2006.08.019 (Pubitemid 44828130)
30. K Mokbel 2005 Contemporary treatment of ductal carcinoma in situ of the breast Med Sci Monit 11 RA86 RA93 15735580
31. MJ Silverstein A Barth DN Poller, et al. 1995 Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast Eur J Cancer 31A 1425 1427 10.1016/0959-8049(95)00283-O 7577065 10.1016/0959-8049(95)00283-O 1:STN:280:DyaK28%2FptV2ruw%3D%3D
32. AP Schouten van der Velden R van Vugt JA Van Dijck, et al. 2007 Local recurrences after different treatment strategies for ductal carcinoma in situ of the breast: a population-based study in the East Netherlands Int J Radiat Oncol Biol Phys 69 703 710 17544591
33. ER Fisher J Dignam E Tan-Chiu, et al. 1999 Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma Cancer 86 429 438 10.1002/(SICI)1097-0142(19990801) 86:3<429::AID-CNCR11>3.0.CO;2-Y 10430251 10.1002/(SICI)1097-0142(19990801) 86:3<429::AID-CNCR11>3.0.CO;2-Y 1:STN:280:DyaK1Mzlslehsg%3D%3D (Pubitemid 29347405)
34. AC Neuschatz T DiPetrillo M Steinhoff, et al. 2002 The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast Cancer 94 1917 1924 10.1002/cncr.10460 11932892 10.1002/cncr.10460 (Pubitemid 34270043)
35. MR Porembka RL Abraham JA Sefko, et al. 2008 Factors associated with lymph node assessment in ductal carcinoma in situ: analysis of 1988-2002 seer data Ann Surg Oncol 15 2709 2719 10.1245/s10434-008-9947-5 18483831 10.1245/s10434-008-9947-5
36. CE Cox K Nguyen RJ Gray, et al. 2001 Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg 67 513 519 11409797 1:STN:280:DC%2BD3MzkslSnsQ%3D%3D (discussion 519-521)
37. B Cutuli 2004 Is radiotherapy needed after adequate local excision of localized DCIS? Int J Fertil Womens Med 49 231 236 15633482
38. SO Emdin B Granstrand A Ringberg, et al. 2006 SweDCIS: radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening Acta Oncol 45 536 543 10.1080/02841860600681569 16864166 10.1080/02841860600681569 (Pubitemid 44167203)
39. A Ringberg H Nordgren S Thorstensson, et al. 2007 Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast-results from the Swedish randomised trial Eur J Cancer 43 291 298 10.1016/j.ejca.2006.09.018 17118648 10.1016/j.ejca.2006.09.018 1:STN:280:DC%2BD2s%2FkvVOltg%3D%3D (Pubitemid 46123991)
40. GA Viani EJ Stefano SL Afonso, et al. 2007 Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials Radiat Oncol 2 28 10.1186/1748-717X-2-28 17683529 10.1186/1748-717X-2-28
41. VC Jordan 2006 Optimising endocrine approaches for the chemoprevention of breast cancer beyond the Study of Tamoxifen and Raloxifene (STAR) trial Eur J Cancer 42 2909 2913 10.1016/j.ejca.2006.09.012 17064889 10.1016/j.ejca.2006.09. 012 1:CAS:528:DC%2BD28XhtFOjt7fL (Pubitemid 44667488)
42. B Cutuli 2000 Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of protocol B-17: intraductal carcinoma Cancer 88 1976 1977 10.1002/(SICI)1097-0142(20000415)88:8<1976::AID- CNCR29>3.0.CO;2-P 10760777 10.1002/(SICI)1097-0142(20000415)88:8<1976:: AID-CNCR29>3.0.CO;2-P 1:STN:280:DC%2BD3c3isFKisQ%3D%3D (Pubitemid 30213010)